168 related articles for article (PubMed ID: 11748216)
1. Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP.
Coles B; Bloodsworth A; Eiserich JP; Coffey MJ; McLoughlin RM; Giddings JC; Lewis MJ; Haslam RJ; Freeman BA; O'Donnell VB
J Biol Chem; 2002 Feb; 277(8):5832-40. PubMed ID: 11748216
[TBL] [Abstract][Full Text] [Related]
2. Nitrolinoleate inhibits superoxide generation, degranulation, and integrin expression by human neutrophils: novel antiinflammatory properties of nitric oxide-derived reactive species in vascular cells.
Coles B; Bloodsworth A; Clark SR; Lewis MJ; Cross AR; Freeman BA; O'Donnell VB
Circ Res; 2002 Sep; 91(5):375-81. PubMed ID: 12215485
[TBL] [Abstract][Full Text] [Related]
3. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
4. Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3A.
Zhang W; Colman RW
Blood; 2007 Sep; 110(5):1475-82. PubMed ID: 17392505
[TBL] [Abstract][Full Text] [Related]
5. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet effects of caffeic acid due to Ca(2＋) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
[TBL] [Abstract][Full Text] [Related]
7. Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein.
Sabetkar M; Naseem KM; Tullett JM; Friebe A; Koesling D; Bruckdorfer KR
Nitric Oxide; 2001 Jun; 5(3):233-42. PubMed ID: 11384196
[TBL] [Abstract][Full Text] [Related]
8. cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.
Makhoul S; Trabold K; Gambaryan S; Tenzer S; Pillitteri D; Walter U; Jurk K
Cell Commun Signal; 2019 Sep; 17(1):122. PubMed ID: 31519182
[TBL] [Abstract][Full Text] [Related]
9. Cyclic nucleotides modulate store-mediated calcium entry through the activation of protein-tyrosine phosphatases and altered actin polymerization in human platelets.
Rosado JA; Porras T; Conde M; Sage SO
J Biol Chem; 2001 May; 276(19):15666-75. PubMed ID: 11278478
[TBL] [Abstract][Full Text] [Related]
10. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
[TBL] [Abstract][Full Text] [Related]
11. Cyclic nucleotides and mitogen-activated protein kinases: regulation of simvastatin in platelet activation.
Lee YM; Chen WF; Chou DS; Jayakumar T; Hou SY; Lee JJ; Hsiao G; Sheu JR
J Biomed Sci; 2010 Jun; 17(1):45. PubMed ID: 20525309
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet activity of caffeic acid phenethyl ester is mediated through a cyclic GMP-dependent pathway in human platelets.
Chen TG; Lee JJ; Lin KH; Shen CH; Chou DS; Sheu JR
Chin J Physiol; 2007 Jun; 50(3):121-6. PubMed ID: 17867432
[TBL] [Abstract][Full Text] [Related]
13. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
Aktas B; Utz A; Hoenig-Liedl P; Walter U; Geiger J
Stroke; 2003 Mar; 34(3):764-9. PubMed ID: 12624305
[TBL] [Abstract][Full Text] [Related]
14. Synergistic phosphorylation of the focal adhesion-associated vasodilator-stimulated phosphoprotein in intact human platelets in response to cGMP- and cAMP-elevating platelet inhibitors.
Nolte C; Eigenthaler M; Horstrup K; Hönig-Liedl P; Walter U
Biochem Pharmacol; 1994 Oct; 48(8):1569-75. PubMed ID: 7980622
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by sodium nitroprusside or PGE1 of tyrosine phosphorylation induced in platelets by thrombin or ADP.
Oda A; Druker BJ; Smith M; Salzman EW
Am J Physiol; 1992 Mar; 262(3 Pt 1):C701-7. PubMed ID: 1372480
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate has an anti-platelet effect in a cyclic AMP-dependent manner.
Ok WJ; Cho HJ; Kim HH; Lee DH; Kang HY; Kwon HW; Rhee MH; Kim M; Park HJ
J Atheroscler Thromb; 2012; 19(4):337-48. PubMed ID: 22498765
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic activities of ferulic acid via intracellular cyclic nucleotide signaling.
Hong Q; Ma ZC; Huang H; Wang YG; Tan HL; Xiao CR; Liang QD; Zhang HT; Gao Y
Eur J Pharmacol; 2016 Apr; 777():1-8. PubMed ID: 26948317
[TBL] [Abstract][Full Text] [Related]
19. Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets.
Geiger J; Nolte C; Butt E; Sage SO; Walter U
Proc Natl Acad Sci U S A; 1992 Feb; 89(3):1031-5. PubMed ID: 1310537
[TBL] [Abstract][Full Text] [Related]
20. Elevation of cAMP, but not cGMP, inhibits thrombin-stimulated tyrosine phosphorylation in human platelets.
Pumiglia KM; Huang CK; Feinstein MB
Biochem Biophys Res Commun; 1990 Sep; 171(2):738-45. PubMed ID: 1698364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
